DRUG · Unmapped registry intervention
Semorinemab
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of Semorinemab in Patients With Moderate Alzheimer's Disease
NCT03828747
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
[18F]GTP1
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of Semorinemab in Patients With Moderate Alzheimer's Disease
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Alzheimer's Diseaseverified · MONDO: Alzheimer disease
Interventions
Sponsors & collaborators
Genentech, Inc.lead sponsor
Mapped research locations
BarcelonaSpain3WarsawPoland2ValenciaSpain2BostonMassachusetts, United States1ChicagoIllinois, United States1MiamiFlorida, United States1ParisFrance1San DiegoCalifornia, United States1PortlandOregon, United States1OrlandoFlorida, United States1RochesterNew York, United States1New HavenConnecticut, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03828747 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.